Nipple reconstruction implant
US-2024238077-A1 · Jul 18, 2024 · US
US9226797B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9226797-B2 |
| Application number | US-201214255952-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 17, 2012 |
| Priority date | Nov 4, 2012 |
| Publication date | Jan 5, 2016 |
| Grant date | Jan 5, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems and methods are disclosed for cosmetic injection. The apparatus includes a processor; a 3D imaging system coupled to the processor; and an injector controlled by the processor to inject filler into a patient.
Opening claim text (preview).
What is claimed is: 1. A method to perform cosmetic enhancements using a body sensor to provide body patient data to a processor and an injector controlled by the processor to inject filler into a patient, comprising capturing a 3D model of a patient body portion using one or more cameras; modeling shape and size change in the body portion due to an implant; iteratively changing modeled body shapes or sizes until the patient is satisfied with a desired shape or size; controlling the injector to deliver the implant in the patient; and monitoring injection into patient and providing feedback if needed to achieve the desired shape and size. 2. The method of claim 1 , comprising morphing or project the shape/size of breast or butt increase onto the 3D model of patient. 3. The method of claim 1 , comprising allowing a user to select from a library of wardrobes to provide realistic post-implant simulation. 4. The method of claim 1 , comprising injecting a polymer into a shell of a soft tissue human implant prior to or during implantation of the shell with a lumen in a human body. 5. The method of claim 1 , comprising cross-linking the polymer, wherein a cross linking reaction occurs outside a shell or in-situ inside the shell. 6. The method of claim 1 , wherein the polymer comprises one of: collagens, hyaluronic acids, celluloses, proteins, saccharides. 7. The method of claim 1 , wherein the polymer comprises an extracellular matrix of a biological system. 8. The method of claim 1 , comprising using cross linkers and forming homo-polymers or to form copolymers by crosslinking with other polymer species. 9. The method of claim 1 , comprising controlling drug releases at predetermined timing in anticipation of an onset of a negative physiological event in response to invading foreign bodies. 10. The method of claim 1 , comprising injecting anesthetics, lidocaine or compound to reduce or eliminate acute inflammatory reactions to the pharmaceutical substance. 11. The method of claim 1 , comprising adding one or more compositions selected from the group consisting of steroids, corticosteroids, dexamethasone, triamcinolone. 12. An apparatus, comprising: a processor; a body sensor to provide body patient data to the processor; and an injector controlled by the processor to inject filler into a patient. 13. The apparatus of claim 12 , wherein the injector includes a medicament container, a needle, an energy source, and a regulator. 14. The apparatus of claim 13 , wherein the injector medicament container has a piston movably disposed therein such that the medicament container is divided into a first portion and a second portion. 15. The apparatus of claim 14 , wherein the first portion of the medicament container is configured to contain a filler, wherein the needle is coupled to the medicament container such that the needle is in fluid communication with the first portion of the medicament container. 16. The apparatus of claim 1 , comprising a mechanical pump to inject the biocompatible cross-linked polymer under soft tissue in a minimally invasive manner. 17. The apparatus of claim 12 , wherein the processor optimizes degradation profile of the composition and minimizing migration of the composition. 18. The apparatus of claim 12 , wherein the filler has a predetermined number average molecular weight (Mn) and the polydispersity index, wherein the filler maintains a consistency of the composition in particle size and population densities, and wherein the filler comprises co-cross-linked glycosaminoglycan chemically with at least one other polymer including hyaluronan or hylan. 19. The apparatus of claim 12 , wherein the processor continuously updates the current shape of breast or butt from a 3D model of the patient to fit to a desired shape. 20. The apparatus of claim 12 , wherein the body sensor comprises a contact sensor or a contactless sensor.
Mammary prostheses · CPC title
Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 {, A61M5/46} take precedence; {hypodermic projectiles F42B12/54}) · CPC title
Human Necessities · mapped topic
Prostheses implantable into the body · CPC title
Human Necessities · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.